Spring Meeting of the
Swiss Physiological Society, March 9, 2001
Asher-Hess Prize
Abstracts selected for oral presentation
|
HIF-1a
iS IMPLICATED IN EMBRYONIC STEM (ES) CELL
GROWTH AND TUMORIGENESIS |
|
G. Höpfl1,
R. H. Wenger1, T. Stallmach2, M. Gassmann1, and I.
Desbaillets1* |
|
Rapid tumor growth is accompanied by the appearance of hypoxic/anoxic regions due to the lack of oxygen supply to the tumor cells. The hypoxia-inducible factor (HIF)-1a is known to induce a number of oxygen-dependent genes, including the angiogenic factor VEGF (vascular endothelial growth factor) which induces new blood vessel formation and therefore allows tumor oxygenation. To determine the role of HIF-1a in cell growth and tumorigenesis, we have generated HIF-1a-deficient (HIF-1a-/-) ES cells by homologous recombination. We found that HIF-1a+/+ ES cells grow slower than HIF-1a-/- ES cells, when differentiated as monolayers in normoxia (21% O2), the opposite occuring in hypoxia (1% O2). Similar results are obtained by in vitro differentiation of these cells into embryoid bodies, suggesting that HIF-1a deficiency might cause cell growth arrest under low oxygen concentrations. To confirm these in vitro data, we injected the HIF-1a+/+ and HIF-1a-/- ES cells subcutaneously into nude mice allowing teratocarcinoma formation. Tumors originating from HIF-1a+/+ ES cells (n=10) grew faster than the ones from HIF-1a-/- cells. Interestingly, when HIF-1a+/+ ES cells were added to HIF-1a-/- ES cells at a proportion of only 1%, tumors developed as fast as the 100% HIF-1a+/+ tumors. The same vessel density was observed in all tumors and HIF-1a+/+ cells did not overgrow the HIF-1a-/- during mixed tumor formation. Therefore HIF-1a+/+ cells secrete factors that support the growth of the HIF-1a-/-cells. |